LQDA

Liquidia Corporation

Price

$75.33

return (12m)

177.87%

p/e

49.01

p/bv

34.82

DIVIDEND YIELD

0.00%

LQDA price

Liquidia

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LQDA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.60%

3 months

21.56%

1 year

177.87%

2 years

669.46%

5 years

2,808.49%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals LQDA

Valuation

P/E

49.01

Sector -4.38

Industry -4.38

P/BV

34.82

Sector 2.02

Industry 2.02

P/Revenue (PSR)

15.07

Sector -4.40

Industry -4.40

EV/EBITDA

75.02

Sector -263.09

Industry -263.09

EV/EBIT

75.36

Sector -702.90

Industry -702.90

P/EBITDA

38.20

Sector -4.39

Industry -4.39

P/EBIT

38.57

Sector -4.73

Industry -4.73

P/Total Assets

13.02

Sector 1.49

Industry 1.49

P/Net Current Assets

61.25

Sector -11.70

Industry -11.70

P/Working Capital

27.35

Sector -3.19

Industry -3.19

EPS

1.56

Sector -2.14

Industry -2.14

BVPS

2.19

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

92.54%

Sector 36.74%

Industry 36.74%

EBITDA Margin

51.49%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

51.25%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

37.39%

Sector -38.22%

Industry -38.22%

Net Profit Margins

30.74%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.33

Sector 0.03

Industry 0.03

Profitability

ROE

71.04%

Sector -65.14%

Industry -65.14%

ROA

26.56%

Sector -65.53%

Industry -65.53%

ROIC

226.35%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.31

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-1.83

Sector -6.07

Industry -6.07

Net Debt / EBIT

-1.84

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.83

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.63

Sector -0.05

Industry -0.05

Equity/Assets

0.37

Sector 0.41

Industry 0.41

Liabilities/Assets

0.63

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

103.72%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Liquidia ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$75.33

Fair Value

$8.77

Upside Return potential.

-88.36%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LQDA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LQDA Liquidia Corporation	$75.33	171.75%	0.00%	49.01	34.82	71.04%	30.74%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LQDA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Liquidia

Liquidia Corporation

Average Investor10 user rating

4.0 (2 people)

United States

22 years

Founded: 2004

2018

Time since IPO - 8 years

64

Employees

Liquidia Corporation (United States) is listed on the Nasdaq and has a market capitalization of $6.79 billion, with shareholders equity totaling $195.11 million.

The company employs approximately 64 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Liquidia Corporation reported $450.91 million in revenue, generating net income of $138.60 million.

Key financial metrics include a P/E ratio of 49.01, a price-to-book (P/B) ratio of 34.82, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LQDA.

Market cap

$6.79 billion

Net worth

$195.11 million

$195,110,000.00

Assets

$521.92 million

$521,920,000.00

Total Shares Outstanding

89.00 million

89,000,000

Average Daily Trading Volume

$2.06 million

$2,060,902.00

Sector

Health Care

Industry

Biotechnology

LQDA

LQDA revenue and profits

Financial Results LQDA

DRAG THE FRAME TO SEE MORE DATA

LQDA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Liquidia (LQDA) today?

A cotação de Liquidia (LQDA) hoje está em US$ 75.33, com uma variação de 177.87% em relação ao último ano. A cotação de Liquidia (LQDA) iniciou o ano negociando na casa dos US$ 34.49 e hoje está em US$ 75.33. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Liquidia (LQDA) e dados de ações do Ibovespa e mercados internacionais.

Quando Liquidia (LQDA) paga dividendos?

Liquidia (LQDA) não distribuiu dividendos no último ano.

Is Liquidia (LQDA) a good investment?

Atualmente, Liquidia (LQDA) está cotada a US$ 75.33, com um P/L de 49.01, representando um desvio de -446% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 177.87 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 177.87%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Liquidia (LQDA) stock?

Investir em ações de Liquidia (LQDA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Liquidia (LQDA) yield today?

A rentabilidade de Liquidia (LQDA) foi de -6.60% no último mês, 177.87% no último ano e 2,808.49% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Liquidia (LQDA) hoje, o investimento total seria de US$ 7,533.00, com base na cotação atual de US$ 75.33.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 20,931.95
Em 5 anos: US$ 219,096.55
Em 10 anos: US$ 7,533.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LQDA

Liquidia Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LQDA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING LQDA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Liquidia

Liquidia Corporation

United States

22 years

2018

64

PROFIT X PRICE LQDA

Financial Results LQDA

LQDA cash flow

Asset, Revenue and Profit Growth - LQDA

LQDA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions